COVAXIN
COVID-19 Vaccination for Children: Bharat Biotech's COVAXIN Gets Emergency Use Approval From DCGI for Kids Above 12 Years
India Supplies 70% of World’s Vaccine Requirement, Says Union Health Minister Mansukh Mandaviya in Lok Sabha
ZyCoV-D, COVID-19 Vaccine Developed by Zydus Cadila, To Be Introduced in These Seven States Initially
COVID-19 Vaccine Covaxin for 2-18 Years: Centre Examining Expert Committee's Recommendations, Informs Union Health Ministry in Rajya Sabha
Covaxin Shows 50% Effectiveness Against Symptomatic COVID-19 in Real-World Assessment: Lancet Study
COVID-19 Vaccine Covaxin True Example of Public-Private Partnership, Says ICMR Director General Balram Bhargava
COVID-19 Vaccination in India: Over 115.73 Crore Doses of Vaccine Administered in The Country So Far
COVID-19 Vaccination In India: Over 115 Crore Doses of Vaccine Administered in The Country So Far
Bharat Biotech's COVID-19 Vaccine Covaxin 77.8% Effective Against Coronavirus, Says Lancet Study
Covaxin Phase 3 Trial Update: Bharat Biotech's COVID-19 Vaccine Data Shows 77% Efficacy, Says Lancent
UK To Recognise Indian Travellers Inoculated With Covaxin From Nov 22, No Self-Isolation Required
UK To Add India’s COVID-19 Vaccine Covaxin to Approved List From November 22, No Quarantine For Fully Vaccinated Travellers
Google Trends